InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Link David Charles, Director. Director active across 1 company, notably SAB Biotherapeutics, Inc.. In total, 2 disclosures have been logged. History available since 7 December 2022. The latest transaction was disclosed on 7 December 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
David Charles Link is a Board Member at SAB Biotherapeutics, Inc. He participates in the governance of the company, contributing to strategic decision-making and oversight of operations. His experience in the biopharmaceutical sector is an asset to the board.